Weighing Alli's impact. Eating disorder patients might be tempted to abuse the first FDA-approved nonprescription diet pill.
Cumella
Edward J
EJ
Remuda Programs for Eating Disorders, USA. edward.cumella@remudaranch.com
Hahn
Judy
J
Woods
Brenda K
BK
D019440:Anti-Obesity Agents; D000075202:Contraindications; D001068:Feeding and Eating Disorders; D006801:Humans; D007783:Lactones; D000077403:Orlistat; D014481:United States
D019440:Anti-Obesity Agents; D007783:Lactones; D000077403:Orlistat